Quality of life improvement following cardioneuroablation for vasovagal syncope: expected or too early to say?
- PMID: 36705871
- DOI: 10.1007/s10840-023-01489-w
Quality of life improvement following cardioneuroablation for vasovagal syncope: expected or too early to say?
Conflict of interest statement
Declarations. Conflict of interest: Bosky Soni declares no conflict of interest. Dhiraj Gupta: principal investigator for institutional research grants from Boston Scientific and proctor for Abbott Ltd. Rakesh Gopinathannair: consultant/honoraria: Abbott Medical, Boston Scientific, and Sanofi: advisory board: PaceMate (no compensation).
References
-
- Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Grubb BP, Hamdan MH, Krahn AD, Link MS, Olshansky B, Raj SR, Sandhu RK, Sorajja D, Sun BC, Yancy CW. 2017 ACC/AHA/HRS Guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70:620–63. - DOI - PubMed
-
- Baron-Esquivias G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, Ruiz-Granell R, Lacunza-Ruiz J, Garcia-Civera R, Gutierrez-Carretero E, Romero-Garrido R. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN Study. J Am Coll Cardiol. 2017;70:1720–8. - DOI - PubMed
-
- Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, Wieling W, Beiras X, Deharo JC, Russo V, Tomaino M, Sutton R. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012;125:2566–71. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
